Deepika Pakianathan insider trades: Mereo BioPharma Group (MREO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Deepika reports to the SEC
and 6 more companies
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 22, 2024 | MREO | ↓ Sell | 105,244 | $4.43 | $466K | Direct | Aug 23, 2024 (1d) |
| Jun 7, 2024 | KPTI | ↓ Sell | 818,044 | $0.96 | $785K | Indirect | Jun 7, 2024 (0d) |
| Jun 4, 2024 | KPTI | ↓ Sell | 906,178 | $0.97 | $881K | Indirect | Jun 4, 2024 (0d) |
| Jan 27, 2023 | CALA | ↓ Sell | 120,161 | $0.39 | $46K | Delphi Ventures VIII, L.P. | Jan 31, 2023 (4d) |
| Jan 27, 2023 | CALA | ↓ Sell | 1,172 | $0.39 | $452 | Delphi BioInvestments VIII, L.P. | Jan 31, 2023 (4d) |
| Jun 10, 2022 | KPTI | ↓ Sell | 538,784 | $6.38 | $3.4M | Indirect | Jun 10, 2022 (0d) |
| Mar 23, 2016 | SENS | ↑ Buy | 1,216,195 | $2.85 | $3.5M | Delphi Ventures VIII, L.P. | Mar 23, 2016 (0d) |
| Mar 23, 2016 | SENS | ↑ Buy | 11,875 | $2.85 | $34K | Delphi BioInvestments VIII, L.P. | Mar 23, 2016 (0d) |
| Jan 12, 2015 | KPTI | ↑ Buy | 45,014 | $33.00 | $1.5M | By Delphi Ventures VIII, L.P. | Jan 14, 2015 (2d) |
| Jan 12, 2015 | KPTI | ↑ Buy | 440 | $33.00 | $15K | By Delphi BioInvestments VIII, L.P. | Jan 14, 2015 (2d) |
| Oct 7, 2014 | CALA | ↑ Buy | 495,165 | $10.00 | $5.0M | Delphi Ventures VIII, L.P. | Oct 9, 2014 (2d) |
| Oct 7, 2014 | CALA | ↑ Buy | 495,165 | $10.00 | $5.0M | Delphi Ventures VIII, L.P. | Oct 9, 2014 (2d) |
| Oct 7, 2014 | CALA | ↑ Buy | 4,835 | $10.00 | $48K | Delphi BioInvestments VIII, L.P. | Oct 9, 2014 (2d) |
| Oct 7, 2014 | CALA | ↑ Buy | 4,835 | $10.00 | $48K | Delphi BioInvestments VIII, L.P. | Oct 9, 2014 (2d) |
| Aug 21, 2014 | OMED | ↑ Buy | 79,457 | $18.98 | $1.5M | By Delphi Ventures VIII, L.P. | Aug 21, 2014 (0d) |
| Aug 21, 2014 | OMED | ↑ Buy | 746 | $18.98 | $14K | By Delphi BioInvestments VIII, L.P. | Aug 21, 2014 (0d) |
| May 23, 2014 | KPTI | ↑ Buy | 113,313 | $26.18 | $3.0M | By Delphi Ventures VIII, L.P. | May 23, 2014 (0d) |
| May 23, 2014 | KPTI | ↑ Buy | 1,106 | $26.18 | $29K | By Delphi BioInvestments VIII, L.P. | May 23, 2014 (0d) |
| May 13, 2014 | ALDR | ↑ Buy | 346,535 | $10.00 | $3.5M | By Delphi Ventures VII, L.P. | May 15, 2014 (2d) |
| May 13, 2014 | ALDR | ↑ Buy | 346,535 | $10.00 | $3.5M | By Delphi Ventures VII, L.P. | May 15, 2014 (2d) |
| May 13, 2014 | ALDR | ↑ Buy | 3,465 | $10.00 | $35K | By Delphi BioInvestments VII, L.P. | May 15, 2014 (2d) |
| May 13, 2014 | ALDR | ↑ Buy | 3,465 | $10.00 | $35K | By Delphi BioInvestments VII, L.P. | May 15, 2014 (2d) |
| Apr 22, 2014 | TRIV | ↑ Buy | 833,333 | $12.00 | $10.0M | Indirect | Apr 24, 2014 (2d) |
| Nov 12, 2013 | KPTI | ↑ Buy | 309,478 | $16.00 | $5.0M | By Delphi Ventures VIII, L.P. | Nov 14, 2013 (2d) |
| Nov 12, 2013 | KPTI | ↑ Buy | 3,022 | $16.00 | $48K | By Delphi BioInvestmentsVIII, L.P. | Nov 14, 2013 (2d) |
| Jul 23, 2013 | OMED | ↑ Buy | 379,127 | $17.00 | $6.4M | By Delphi Ventures VIII, L.P. | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 3,226 | $17.00 | $55K | By Delphi BioInvestments VIII, L.P. | Jul 23, 2013 (0d) |
| Feb 27, 2009 | TSON | ↑ Buy | 50,000 | $5.90 | $295K | Indirect | Mar 3, 2009 (4d) |
| Mar 8, 2006 | ALXA | ↑ Buy | 1,000 | $8.00 | $8K | Direct | Mar 9, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Deepika Pakianathan's insider trades
Deepika Pakianathan is an insider at Mereo BioPharma Group (MREO). Since Mar 8, 2006, Deepika has reported 23 open-market purchases worth $48.3M and 6 sales worth $5.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (53 filings), conversions (10 filings), other transactions (5 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MREO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.